Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like What You Need to Know About DMD Therapeutics January 29, 2018 SomaGenics Inc. Awarded NIH Funding To Develop NGS Single-Cell Analysis Of Small RNAs October 9, 2017 CURE Pharma Launches New Academic Partnership Program Providing The Company???s Proprietary Curefilm For More Humane And Effective Animal Research September 5, 2017
SomaGenics Inc. Awarded NIH Funding To Develop NGS Single-Cell Analysis Of Small RNAs October 9, 2017
CURE Pharma Launches New Academic Partnership Program Providing The Company???s Proprietary Curefilm For More Humane And Effective Animal Research September 5, 2017
